Inventor · disambiguated record
Marlene Michelle Dressman
Also filed as: DRESSMAN MARLENE M · DRESSMAN MARLENE MICHELLE
30 granted patents·12 pending applications·198 citations·filing 2002–2025
97Inventor score
Top patents by PatentIndex Score
42 records- 0198US11285129B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Mar 29, 2022·8 cites·3 claims
- 0298US10980770B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2020·Granted Apr 20, 2021·7 cites·12 claims
- 0398US8785492B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Jul 22, 2014·41 cites·5 claims
- 0497US12201604B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2024·Granted Jan 21, 2025·1 cites·9 claims
- 0597US10610510B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 7, 2020·9 cites·13 claims
- 0697US9060995B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2014·Granted Jun 23, 2015·22 cites·1 claims
- 0796US10149829B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Dec 11, 2018·13 cites·14 claims
- 0896US9549913B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Jan 24, 2017·18 cites·14 claims
- 0996US9539234B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2015·Granted Jan 10, 2017·15 cites·5 claims
- 1095US9730910B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2014·Granted Aug 15, 2017·15 cites·5 claims
- 1194US11918556B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·3 claims
- 1294US11850229B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Dec 26, 2023·1 cites·3 claims
- 1394US11826339B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Nov 28, 2023·1 cites·4 claims
- 1494US11141400B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2020·Granted Oct 12, 2021·3 cites·10 claims
- 1593US11918557B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·10 claims
- 1693US10449176B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·5 cites·9 claims
- 1792US10610511B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Apr 7, 2020·8 cites·19 claims
- 1892US9855241B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·5 cites·9 claims
- 1991US11833130B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·1 cites·10 claims
- 2091US10376487B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2014·Granted Aug 13, 2019·11 cites·20 claims
- 2190US11633377B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Apr 25, 2023·1 cites·11 claims
- 2290US10945988B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·3 cites·13 claims
- 2385US9212129B2Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideVANDA PHARMACEUTICALS INC·Filed 2013·Granted Dec 15, 2015·5 cites·12 claims
- 2480US11013713B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2016·Granted May 25, 2021·1 cites·3 claims
- 2580USRE46604ETreatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·1 cites·8 claims
- 2679US2025161259A1Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2778US11786502B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2021·Granted Oct 17, 2023·0 cites·15 claims
- 2877US2024350451A1Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2976US2024342129A1Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3074US9617203B2Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideVANDA PHARMACEUTICALS INC·Filed 2015·Granted Apr 11, 2017·1 cites·12 claims
- 3173US11090285B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 17, 2021·0 cites·1 claims
- 3273US2023293477A1Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3367US2021128517A1Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3464US10233142B2Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideVANDA PHARMACEUTICALS INC·Filed 2017·Granted Mar 19, 2019·0 cites·6 claims
- 3564US2021299080A1Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3663US9850199B2Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideVANDA PHARMACEUTICALS INC·Filed 2017·Granted Dec 26, 2017·0 cites·2 claims
- 3759US2017304256A1Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3854US2005164196A1Methods to predict patient responsiveness to tyrosine kinase inhibitorsFiled 2003·Application pending·0 cites
- 3953US2007141618A1Genes expressed in breast cancer as prognostic and therapeutic targetsDRESSMAN MARLENE M·Filed 2007·Application pending·0 cites
- 4051US2003064385A1Genes expressed in breast cancer as prognostic and therapeutic targetsFiled 2002·Application pending·0 cites
- 4144US2005181516A1Bioequivalence determination using expression profilingFiled 2003·Application pending·0 cites
- 4241US2006188878A1Methods to predict ederma as a side effect of drug treatmentDRESSMAN MARLENE M·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →